Justice Department to ascertain if GSK contravened US Foreign Corrupt Practices Act.

The National Bureau of Statistics accuses local authorities of forcing companies to inflate ouptut data.

Graft investigators point finger at GSK's China HQ rather than individual salespeople.

The British pharmaceutical giant GlaxoSmithKline's company in China (GSK China) established a key account marketing team to bribe major hospitals, exposed GSK employees.

British fraud investigator Peter Humphrey and wife Yu Yingzeng were detained as part of a corruption probe into China's pharma sector.

Eli Lilly is "deeply concerned" over unverified allegations its staff spent more than 30m yuan to bribe doctors

Humphrey and his wife were being held by Shanghai Police since mid-July.

Senior NDRC official reportedly told 30 foreign firms 'if you put up a fight, I could double or triple your fines'.

France's Sanofi and Britain's GlaxoSmithKline are among foreign firms who were accused of bribery in China

After GlaxoSmithKline, China is probing Sanofi for alleged bribery by staff.

Market participants in the UK will be tracking British trade balance data

GSK's $50m Action Potential Venture Capital Fund's first investment is US-based SetPoint Medical.

GSK's patent for Tykerb revoked after company suffered from bribery allegations in China.

Zhengzhou police detain 18 GlaxoSmithKline employees and some medical personnel.

China's state media on Friday (July 26) revealed details of alleged bribery violations by some Chinese executives of British drugmaker GlaxoSmithKline (GSK).

Gisserot, senior vice-president for Europe at GSK, will replace Mark Reilly as general manager.

British drug maker woes mount in the face of tackling the bribery scandal in China.

Modest Q1 sales rise unlikely to be repeated, says GSK, as it commissions independent review into scandal.

French flash composite PMI rises to 17-month high of 48.8 in July.

Chinese police question American citizen in crackdown on pharmaceutical industry following GlaxoSmithKline (GSK) bribery scandal.

WSJ report says British national is being detained, but not arrested, by Chinese authorities

AstraZeneca employee questioned in Shanghai as Chinese authorities crack down on pharmaceutical sector.

GSK CEO Witty to reveal action against bribery scandal that has rocked pharmaceutical giants.

A senior executive from GlaxoSmithKline (GSK) told Chinese police the British drug-maker will reform its business in the country in the wake of a bribery scandal, China's Ministry of Public Security said on Monday (July 22).

Watchdogs visits UCB office in China to check on compliance procedures.

GSK's British head of finance is banned from leaving China after head of operations Mark Reilly's flight.

China Food and Drug Administration announces six-month campaign to stop sales of illegal medicine.

GlaxoSmithKline executives 'routed payments through 700 travel agencies and consultancies'.

Drugmaker GlaxoSmithKline (GSK) used travel agencies and consultancies as vehicles to bribe officials and doctors and illegally boosted the sales prices of its drugs sold in China, police said on Monday (July 15).

GSK staff in China confess to crimes after initial questioning by Chinese police, says Public Security Bureau